LogicMark, Inc (LGMK) Fair Value & Analysis
Healthcare · US · Market cap $675K
LogicMark, Inc
LGMK · US
Fair value as of: Jul 17, 2026
From 3 valuation models · updated today
Share price −15.8% over the past month.
Price vs Fair Value (12 months)
12‑month range $0.4300 – $4.05 · fair‑value band $0.3232 – $1.01 · the $0.8000 price screens above the $0.6560 fair value. As of Jul 17, 2026.
✦ Which stocks are undervalued right now? Check free Discover now →Analysis
LogicMark, Inc (LGMK) currently trades at $0.8000, while our model-based Fair Value estimate is $0.6560, implying the stock looks roughly 18.0% overvalued today. We read business quality at 28/100 (below-average quality), in the Healthcare sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium, the entry price still matters most (evidence: low).
Over the trailing twelve months, LogicMark, Inc generated revenue of $12.0M at a net margin of -55.8%. Revenue grew 24.0% year over year. It earns a return on equity of -33.9%. The balance sheet holds a net cash position of $3.8M. Fundamentals as of Jul 17, 2026
Our scenario range runs from $0.3232 (bear case) to $1.01 (bull case); at $0.8000, the current price sits within that range. For context, the median of 10 Healthcare peers we cover trades at -37% fair-value upside, at -18%, LGMK screens cheaper than that median.
Key figures & financial health
More key figures
Figures from reported company fundamentals (EODHD) · as of Jul 17, 2026. TTM = trailing twelve months.
About the company
LogicMark, Inc. provides personal emergency response systems (PERS), health communications devices, and Internet of Things (IoT) technology that creates a connected care platform in the United States. The company offers Guardian Alert 911 Plus, Freedom Alert, Freedom Alert Mini, and Freedom Alert Max, which are home-based landline solutions. It also provides Aster, a personal safety app that provides 24/7 monitoring along with a Bluetooth button product. The company was formerly known as Nxt-ID, Inc. and changed its name to LogicMark, Inc. in March 2022. LogicMark, Inc. was incorporated in 2012 and is based in Louisville, Kentucky.
Revenue & earnings trend
FY2021 – FY2025 · reported fiscal years
LogicMark, Inc reported revenue of $11.4M in FY2025 versus $10.0M in FY2021, a compound +3.3%/yr. Reported net income was −$7.5M in FY2025.
Is LGMK fairly valued? → Check now
Similar stocks
10 more Health Information Services stocks, each showing price versus our Fair Value estimate (as of Jul 17, 2026).
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| Veeva Systems Inc VEEV | $172.61 | $104.16 | -40% |
| Pro Medicus Limited PME | A$172.80 | A$32.25 | -81% |
| BrightSpring Health Services, Inc BTSG | $57.40 | $23.87 | -58% |
| Tempus AI, Inc TEM | $48.61 | $12.67 | -74% |
| HealthEquity, Inc HQY | $86.03 | $54.47 | -37% |
| Hinge Health, Inc HNGE | $68.85 | $78.43 | +14% |
| M3, Inc MTHRY | $5.20 | $5.32 | +2% |
| 10x Genomics, Inc TXG | $32.94 | $22.67 | -31% |
| Waystar Holding WAY | $18.41 | $12.86 | -30% |
| Ping An Healthcare and Technology Company PANHF | $0.9000 | $0.5700 | -37% |
Explore undervalued stocks
More undervalued Healthcare stocks →
Frequently asked questions
Is LogicMark, Inc (LGMK) undervalued?
What is the fair value of LGMK?
What is the quality score of LGMK?
What is the revenue of LogicMark, Inc (LGMK)?
What is the net profit margin of LGMK?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data, nothing guessed.
Unlock the full LogicMark, Inc analysis, and try Pro free
One email gets you 14 days of full Pro (review alerts, the 35,000+ stock screener, the diversification check) plus the monthly Top-25 report of the most undervalued quality stocks. No card, cancel anytime.
Zero risk: nothing is ever charged. After 14 days you decide whether to stay.
Not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.